# Changrong Capital

Changrong Capital is an Asset Manager based in 厦门, China.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** 厦门, China
- **Region:** Asia
- **Address:** Shenzhen, China
- **Founded:** 2007
- **Assets under management:** Undisclosed
- **Website:** www.xmcrcapital.cn

## Regulatory record

- **Reports private funds:** No

## About

Changrong Capital is a venture capital firm based in China. It focuses on investments in healthcare, environmental protection, non-ferrous metals, cultural & creative industries, TMT, and artificial intelligence. The firm has made 20 investments, including a Series A investment in Amberstone Biosciences on January 03, 2022.

## Sectors

- Healthcare
- Artificial Intelligence
- Semiconductors
- New Energy

## Offices

- Xiamen, China
- Hong Kong, China
- Chongqing, China
- Sunnyvale, United States

## Questions

### Who makes investment decisions at Changrong Capital?

The firm does not publicly identify its investment decision-makers. No named principals or executives appear in public records, filings, or media reports. This level of opacity is common among certain Chinese family offices and asset managers that operate without a public marketing presence.

### Where does Changrong Capital invest?

The firm's office locations—Shenzhen, Xiamen, Hong Kong, Chongqing, and Sunnyvale—suggest a dual focus on the Chinese domestic market and US technology investments. Sunnyvale, California, positions the firm within proximity to Silicon Valley venture ecosystems. Exact sector or stage preferences are not documented.

## Related profiles

- [ZK Capital](https://altss.com/profile/zk-capital)
- [Codex DNA](https://altss.com/profile/codex-dna)

---

Last updated: 2026-07-10T21:29:47.000Z

Canonical page: https://altss.com/profile/changrong-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology